We are live on ! Find out more
PIII icon

P3 Health Partners

8.00 USD
+0.03
0.38%
At close Updated Sep 16, 11:23 AM EDT
1 day
0.38%
5 days
-4.76%
1 month
-24.31%
3 months
-29.52%
6 months
163.16%
Year to date
128.57%
1 year
-4.53%
5 years
-98.37%
10 years
-98.35%
 

About: P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all. It includes utilization management, care management, disease education, and maintenance of a quality improvement and quality management program for members assigned to the Company. The Company is also responsible for the credentialing of its providers, processing and payment of claims, and the establishment of a provider network for certain health plans.

Employees: 320

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 25%
Neutral 75%
Negative 0%
Positive
MarketBeat
1 month ago
P3 Health Partners Q2 Earnings Call Highlights
P3 Health Partners NASDAQ: PIII reported second-quarter adjusted EBITDA of $54 million and raised its full-year 2026 outlook, while noting that the quarterly result included $45 million of favorable payer settlements and prior-year development.
P3 Health Partners Q2 Earnings Call Highlights
Neutral
Seeking Alpha
1 month ago
P3 Health Partners Inc. (PIII) Q2 2026 Earnings Call Transcript
P3 Health Partners Inc. (PIII) Q2 2026 Earnings Call Transcript
P3 Health Partners Inc. (PIII) Q2 2026 Earnings Call Transcript
Neutral
Business Wire
1 month ago
P3 Health Partners Announces Second Quarter 2026 Results
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the second quarter ended June 30, 2026. "Q2 demonstrates that the business is now executing according to our plan. We delivered $54 million of adjusted EBITDA, with the core business driving improved profitability quarter over quarter. Our results reflect the structural improvements.
P3 Health Partners Announces Second Quarter 2026 Results
Neutral
Business Wire
1 month ago
P3 Health Partners Schedules Second Quarter 2026 Earnings Release and Conference Call
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for second quarter 2026 on Monday, August 10, 2026. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/ 4:30pm ET the same day. Title & Webcast P3 Health Second Quarter 2026 Earnings C.
P3 Health Partners Schedules Second Quarter 2026 Earnings Release and Conference Call
Positive
24/7 Wall Street
4 months ago
Trump Rattled Markets Again and These 3 Forgotten Stocks Under $30 Were the Unlikely Winners
President Trump's 12-word remark, “I don't think about Americans' financial situation, I don't think about anybody,” hit the wires, and the reaction showed up in the forgotten corners of the market, where micro-cap turnarounds priced like option contracts ripped higher on May 15 as traders rotated into beaten-down names with operational catalysts already in motion.
Trump Rattled Markets Again and These 3 Forgotten Stocks Under $30 Were the Unlikely Winners
Neutral
Seeking Alpha
4 months ago
P3 Health Partners Inc. (PIII) Q1 2026 Earnings Call Transcript
P3 Health Partners Inc. (PIII) Q1 2026 Earnings Call Transcript
P3 Health Partners Inc. (PIII) Q1 2026 Earnings Call Transcript
Neutral
Business Wire
4 months ago
P3 Health Partners Announces First Quarter 2026 Results
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the first quarter ended March 31, 2026. "Q1 represents a meaningful turning point for the business. The $26 million of adjusted EBITDA we delivered this quarter reflects the cumulative impact of two years of deliberate work, including contract restructuring, network concentration, an.
P3 Health Partners Announces First Quarter 2026 Results
Neutral
Business Wire
5 months ago
P3 Health Partners Schedules First Quarter 2026 Earnings Release and Conference Call
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for first quarter 2026 on Thursday, May 14, 2026. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/ 4:30pm ET the same day. Title & Webcast P3 Health First Quarter 2026 Earnings Conf.
P3 Health Partners Schedules First Quarter 2026 Earnings Release and Conference Call
Neutral
Seeking Alpha
5 months ago
P3 Health Partners Inc. (PIII) Q4 2025 Earnings Call Transcript
P3 Health Partners Inc. (PIII) Q4 2025 Earnings Call Transcript
P3 Health Partners Inc. (PIII) Q4 2025 Earnings Call Transcript
Neutral
Business Wire
5 months ago
P3 Health Partners Announces Fourth Quarter and Full Year 2025 Results
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the fourth quarter and full year ended December 31, 2025, and provided 2026 guidance. "2025 was a year of meaningful progress in repositioning the business. We strengthened our contract economics, improved provider alignment, and built a more disciplined operating foundation. With th.
P3 Health Partners Announces Fourth Quarter and Full Year 2025 Results
Price charts implemented using Lightweight Charts™